Favipiravir Market Supplier, Demand Analysis, Regions and Forecast – 2031

The global favipiravir market is anticipated to grow at a CAGR of 4.1% during the forecast period. Favipiravir is a broad-spectrum antiviral that has shown promise in the treatment of influenza virus infections, Ebola, COVID-19, and others. With the surging prevalence of such diseases, the demand for favipiravir is also growing at an alarming rate, thereby driving the market growth. As per the Centers for Disease Control and Prevention estimates, there were 9 million – 41 million illnesses, 140,000 – 710,000 hospitalizations, and 12,000 – 52,000 mortality reported in 2020 due to influenza virus infections. Furthermore, the usage of favipiravir drugs in the treatment of COVID-19 is also expected to create new growth opportunities. However, clinical trials are going on in the US, Italy, and Japan and as of now, it is believed that the drug could come out as a potential treatment for COVID-19. As favipiravir possesses high utility for treating patients with COVID-19. For instance, in May 2020, the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and the ChemRar Group announced the start of the final stage of the multicenter randomized open comparative clinical trial of the drug Favipiravir on patients hospitalized with a COVID-19. 

Get Free Sample link @ https://www.omrglobal.com/request-sample/favipiravir-market

Apart from these, favipiravir is also considered an effective drug for Ebola. This anti-viral medication works by inhibiting the viral RNA polymerase in the replication of virus infection within infected cells. The use of favipiravir has resulted in fewer deaths due to this disease when compared with earlier times. In addition, the other factors that are also contributing effectively to the growth of the market include the growing demand for biological drugs and increasing R&D investments for novel drug development. 

Segmental Outlook  

The global favipiravir market is segmented based on application and distribution channels. Based on application, the market is sub-segmented into Influenza A&B, Ebola, COVID-19, and others. Among these, the Influenza A&B segment is expected to hold a considerable share in the market. Favipiravir is primarily used in the treatment of Influenza A&B as it is active against influenza A and B viruses including strains that are resistant to other classes of antiviral drugs. The high prevalence of Influenza is the foremost factor boosting the demand for favipiravir, hence driving the segment growth. Similarly, based on distribution channels, the market is sub-segmented into hospitals & clinics, drug stores/pharmacies, and online. Among these, the hospitals & clinics segment is expected to hold the highest share in the market during the forecast period due to the increasing number of hospitals & clinics globally and significant investment in healthcare by the population, and supportive government initiatives toward healthcare infrastructure development. 

Full report of Favipiravir Market available @ https://www.omrglobal.com/industry-reports/favipiravir-market

Regional Outlook 

Geographically, the global favipiravir market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). North America will contribute a significant share of overall market growth. The region has a high presence of patients affected with Ebola and SARS and due to this, the demand for favipiravir drugs is also high. In addition, the growing geriatric population with numerous viral outbreaks, and increasing demand for influenza treatment are the supportive factors for the market growth.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/favipiravir-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Article source: https://article-realm.com/article/Business/70630-Favipiravir-Market-Supplier-Demand-Analysis-Regions-and-Forecast-2031.html